·   Log in

Archive for April 22nd, 2010

Prana Biotech’s new drug PBT2 to be tested in Alzheimer’s patients

Thursday, April 22, 2010 21:08

Prana Biotechnology is initiating a clinical study to test the efficacy of its investigational compound PBT2 in Alzheimer’s disease patients.

This was posted under category: Clinical Trials  |  Read Full Story  |  1 Comment

Telcagepant and topiramate offer new hope for migraine sufferers, says study

Thursday, April 22, 2010 20:31

Telcagepant and topiramate are having the potential to become new treatment for migraine headache, according to a study in Lancet.

This was posted under category: Discoveries  |  Read Full Story  |  0 Comments
Tagged with:

Glenmark moves closer to launch ezetimibe (Zetia) generic pill as US court rejects most of Merck’s patent claims

Thursday, April 22, 2010 15:28

India's Glenmark Pharmaceuticals has moved closer to launch a version of cholesterol pill ezetimibe (Zetia) in US even as a US court rejected ten out of over a dozen patent claims made by Merck against the firm to block the generic.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: , ,

Pollen-derived Oralair to treat allergic conjunctivitis is promising: Stallergenes

Thursday, April 22, 2010 6:18

Oralair, an experimental drug to treat allergic rhino-conjunctivitis by Stallergenes, has been found highly promising in late phase clinical studies.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments